Using hydrogels to improve bone repair with DBM and exosome mimetics
Hydrogel delivery of DBM and exosome mimetics for bone repair
This study is looking at a new way to help people with facial bone injuries heal better by using a special gel that delivers helpful materials to boost bone growth, making recovery more effective and reliable.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11098421 on NIH RePORTER |
What this research studies
This research focuses on enhancing bone regeneration for patients with craniofacial defects by using a special hydrogel that delivers demineralized bone matrix (DBM) and exosome mimetics. The approach aims to stabilize DBM particles and improve their effectiveness at the site of injury, addressing the limitations of current treatments. By utilizing RNA interference to reduce the effects of natural BMP antagonists, the study seeks to enhance the osteogenic properties of DBM. This innovative method could lead to more predictable and effective bone healing outcomes for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with congenital or acquired craniofacial defects requiring bone repair.
Not a fit: Patients with conditions unrelated to bone repair or those who do not have craniofacial defects may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a more effective treatment option for patients with bone repair needs, leading to improved healing and recovery.
How similar studies have performed: While the use of hydrogels and exosome mimetics in bone repair is a novel approach, similar strategies have shown promise in other areas of regenerative medicine.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Lee, Min — University of California Los Angeles
- Study coordinator: Lee, Min
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.